AMYLOID

Clinical trials for AMYLOID explained in plain language.

Never miss a new study

Get alerted when new AMYLOID trials appear

Sign up with your email to follow new studies for AMYLOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New hope for Tough-to-Treat amyloidosis: testing a powerful drug trio

Disease control Ongoing

This study is testing whether adding a drug called pomalidomide to two other medications (daratumumab and dexamethasone) works better for people with AL amyloidosis that has come back or stopped responding to prior treatment. It is for patients who have already received daratumum…

Matched conditions: AMYLOID

Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

AMYLOID

Get alerted when new AMYLOID trials appear

New hope for Tough-to-Treat amyloidosis: testing a powerful drug trio